Arpeggio Bio nabs $3.2M to advance nascent RNA drug screen Jan. 16, 2020 By Meg Bryant Boulder, Colo.-based startup Arpeggio Biosciences Inc. scooped up $3.2 million in seed funding in a round led by Khosla Ventures, with participation by Fundersclub, Fifty Years, TechU and Y Combinator.Read More
RSS
